Enhanced Nutraceutical Gel Systems and Methods
Legal Citation
Summary of the Inventive Concept
The present inventive concept relates to novel systems and methods for creating customized nutraceutical gels with improved bioavailability, prolonged shelf life, and enhanced immune modulator delivery.
Background and Problem Solved
The original patent disclosed limitations in terms of fixed compositions and manufacturing processes, which restricted the ability to customize and optimize nutraceutical gels for specific user needs. The present inventive concept addresses these limitations by introducing modular systems and methods that enable the creation of tailored nutraceutical gels with improved performance.
Detailed Description of the Inventive Concept
The inventive concept encompasses four primary aspects: 1) a system for creating customized nutraceutical gels, comprising a gel matrix forming unit and a transfer factor dispensing unit; 2) a method for enhancing the bioavailability of an immune modulator in a nutraceutical gel, involving pH-level optimization; 3) a nutraceutical gel composition incorporating a bioavailability enhancer; and 4) a device for creating nutraceutical gels with customizable immune modulator concentrations. These aspects work in concert to provide a comprehensive solution for the production of optimized nutraceutical gels.
Novelty and Inventive Step
The present inventive concept introduces a paradigm shift in nutraceutical gel manufacturing by providing modular, customizable systems and methods that overcome the fixed composition limitations of the original patent. The use of pH-level optimization, bioavailability enhancers, and customizable immune modulator concentrations represents a significant departure from the prior art.
Alternative Embodiments and Variations
Alternative embodiments may include variations in the gel matrix forming unit, such as the use of different polymers or gelling agents. Additionally, the transfer factor dispensing unit could be modified to accommodate different types of immune modulators or bioavailability enhancers. Further, the device for creating nutraceutical gels could be adapted for use in different settings, such as clinical or commercial environments.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the nutraceutical and pharmaceutical industries, where customized and optimized gel-based products are in high demand. Target markets may include health and wellness companies, pharmaceutical manufacturers, and research institutions seeking to develop novel nutraceutical products.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K36/889 |
| A | A23 | A23G4/12 |
| A | A23 | A23L29/231 |
| A | A23 | A23L29/238 |
| A | A23 | A23L29/27 |
| A | A23 | A23L29/271 |
| A | A23 | A23L29/284 |
| A | A23 | A23L33/10 |
| A | A23 | A23L33/105 |
| A | A61 | A61K36/185 |
| A | A61 | A61K36/35 |
| A | A61 | A61K36/87 |
| A | A61 | A61K47/36 |
| A | A23 | A23V2002/00 |
| A | A23 | A23V2200/324 |
| A | A23 | A23V2250/21 |
| A | A23 | A23V2250/21166 |
| A | A23 | A23V2250/506 |
| A | A23 | A23V2250/5086 |
| A | A23 | A23V2250/708 |
| A | A61 | A61K2300/00 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Nutraceutical formulation and food science, specifically focused on gel-based supplement delivery systems with immune modulators, involving expertise in polymer chemistry, food technology, and nutritional supplement design
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degree in food science, biochemistry, or pharmaceutical sciences, having practical experience in nutraceutical product development, familiar with gel matrix technologies, immune modulator delivery mechanisms, and standard formulation techniques
Obviousness Rationale
A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's core nutraceutical gel technology. The disclosed customization methods, pH optimization, and bioavailability enhancement techniques are logical engineering iterations that would be apparent to someone skilled in nutraceutical formulation. The PTD essentially provides systematic approaches to improving the fundamental gel-based immune modulator delivery concept already established in the source patent.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,593 |
|---|---|
| Title | Nutraceutical gels |
| Assignee(s) | 4Life Patents, LLC |